Giacoletto KS - Search Results

1

Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.

Sant AJ, Cullen SE, Giacoletto KS, Schwartz BD. Sant AJ, et al. Among authors: giacoletto ks. J Exp Med. 1985 Dec 1;162(6):1916-34. doi: 10.1084/jem.162.6.1916. J Exp Med. 1985. PMID: 3864916 Free PMC article.

2

The human invariant chain is the core protein of the human class II-associated proteoglycan.

Giacoletto KS, Sant AJ, Bono C, Gorka J, O'Sullivan DM, Quaranta V, Schwartz BD. Giacoletto KS, et al. J Exp Med. 1986 Nov 1;164(5):1422-39. doi: 10.1084/jem.164.5.1422. J Exp Med. 1986. PMID: 3464690 Free PMC article.

3

Human Ia alpha- and beta-chains are sulfated.

Sant AJ, Zacheis M, Rumbarger T, Giacoletto KS, Schwartz BD. Sant AJ, et al. Among authors: giacoletto ks. J Immunol. 1988 Jan 1;140(1):155-60. J Immunol. 1988. PMID: 3121736

4

Glycosaminoglycan modifications of membrane proteins.

Giacoletto KS, Rumbarger T, Schwartz BD. Giacoletto KS, et al. Methods Cell Biol. 1989;32:207-30. doi: 10.1016/s0091-679x(08)61172-3. Methods Cell Biol. 1989. PMID: 2691851 Review. No abstract available.

5

Analysis of normal human tonsil class II antigen glycosylation by lectin affinity chromatography.

Zacheis M, Giacoletto K, Schwartz BD. Zacheis M, et al. J Biol Chem. 1986 Dec 25;261(36):17004-10. J Biol Chem. 1986. PMID: 3782152 Free article.

6

Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.

Morton PA, Zacheis ML, Giacoletto KS, Manning JA, Schwartz BD. Morton PA, et al. Among authors: giacoletto ks. J Immunol. 1995 Jan 1;154(1):137-50. J Immunol. 1995. PMID: 7995933

7

Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells.

Nygard NR, Giacoletto KS, Bono C, Gorka J, Kompelli S, Schwartz BD. Nygard NR, et al. Among authors: giacoletto ks. J Immunol. 1994 Feb 1;152(3):1082-93. J Immunol. 1994. PMID: 8301118

8

Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.

Nygard NR, Bono C, Brown LR, Gorka J, Giacoletto KS, Schaiff WT, Graham MB, McCourt DW, Kabeer M, Braciale VL, et al. Nygard NR, et al. Among authors: giacoletto ks. J Exp Med. 1991 Jul 1;174(1):243-51. doi: 10.1084/jem.174.1.243. J Exp Med. 1991. PMID: 2056278 Free PMC article.

9

Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).

Morton PA, Fu XT, Stewart JA, Giacoletto KS, White SL, Leysath CE, Evans RJ, Shieh JJ, Karr RW. Morton PA, et al. Among authors: giacoletto ks. J Immunol. 1996 Feb 1;156(3):1047-54. J Immunol. 1996. PMID: 8557978

10

Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

Cross AH, Girard TJ, Giacoletto KS, Evans RJ, Keeling RM, Lin RF, Trotter JL, Karr RW. Cross AH, et al. Among authors: giacoletto ks. J Clin Invest. 1995 Jun;95(6):2783-9. doi: 10.1172/JCI117982. J Clin Invest. 1995. PMID: 7539461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters